Hong Kong · Delayed Price · Currency is HKD Shenzhen Edge Medical Statistics
Total Valuation
HKG:2675 has a market cap or net worth of HKD 20.93 billion. The enterprise value is 20.03 billion.
| Market Cap | 20.93B |
| Enterprise Value | 20.03B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2675 has 391.88 million shares outstanding. The number of shares has decreased by -1.55% in one year.
| Current Share Class | 327.76M |
| Shares Outstanding | 391.88M |
| Shares Change (YoY) | -1.55% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 40.52% |
| Owned by Institutions (%) | 26.57% |
| Float | 100.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 168.31 |
| PS Ratio | 41.26 |
| PB Ratio | 15.69 |
| P/TBV Ratio | 15.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -203.16 |
| EV / Sales | 39.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.11 |
| Quick Ratio | 6.33 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -216.83 |
Financial Efficiency
Return on equity (ROE) is -7.21% and return on invested capital (ROIC) is -5.90%.
| Return on Equity (ROE) | -7.21% |
| Return on Assets (ROA) | -5.34% |
| Return on Invested Capital (ROIC) | -5.90% |
| Return on Capital Employed (ROCE) | -9.61% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.38M |
| Profits Per Employee | -657,352 |
| Employee Count | 150 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 61.60 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.06 |
| Average Volume (20 Days) | 269,759 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2675 had revenue of HKD 507.12 million and -98.60 million in losses. Loss per share was -0.28.
| Revenue | 507.12M |
| Gross Profit | 334.57M |
| Operating Income | -130.54M |
| Pretax Income | -98.60M |
| Net Income | -98.60M |
| EBITDA | -110.27M |
| EBIT | -130.54M |
| Loss Per Share | -0.28 |
Balance Sheet
The company has 905.67 million in cash and 11.01 million in debt, with a net cash position of 894.66 million or 2.28 per share.
| Cash & Cash Equivalents | 905.67M |
| Total Debt | 11.01M |
| Net Cash | 894.66M |
| Net Cash Per Share | 2.28 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 3.82 |
| Working Capital | 1.30B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 20.63M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 65.97%, with operating and profit margins of -25.74% and -19.44%.
| Gross Margin | 65.97% |
| Operating Margin | -25.74% |
| Pretax Margin | -19.44% |
| Profit Margin | -19.44% |
| EBITDA Margin | -21.74% |
| EBIT Margin | -25.74% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2675 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.55% |
| Shareholder Yield | 1.55% |
| Earnings Yield | -0.47% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |